Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06537375
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-01
Brief Title:
Use of Ketamine in Severe Pain Syndromes
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Use of Intravenous Ketamine in Patients With Severe Chronic Pain Syndromes
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Ketamine has been shown to have a certain efficiency in chronic pain syndromes However it is still not clearly known what is its efficiency and how ketamine is used in real world patients In this retrospective study all patients treated with ketamine for chronic pain in our hospital will be reviewed Patients demographics pain syndromes as well as outcome criteria will be collected to describe the use of ketamine in pain syndromes
Detailed Description:
The American Society of Regional Anesthesia and Pain Medicine together with the American Academy of Pain and the American Society of Anesthesiologists published a consensus guideline in 2018 on the use of ketamine in chronic pain A review of medical charts of all patients who received ketamine for chronic pain between january 2010 and june 2024 will be done Demographic data detailed pain scores as well as description of the type of pain will be collected Ketamine usage will be recorded for the dosage as well as duration of the treatment Outcome will be measured by beforeafter pain scores for neuropathic pain as well as on a visual analog scale A more global score good-medium-no effect will also be collected to get the patients impression on their treatment Concomitant pain medication will be collected
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None